Please note that Mounjaro (tirzepatide) is not currently available through our practice for weight loss treatment.
Mounjaro has recently been licensed in the UK for weight management; however, it is not yet available for prescribing on the NHS in this area for this purpose. The North Central London Integrated Care Board (NCL ICB) is reviewing national guidance and local implementation plans, and we are awaiting further updates.
Eligibility criteria, once Mounjaro becomes available, are expected to follow guidance from North Central London Integrated Care Board (NCL ICB). This will likely include:
Patients with a BMI of >40 PLUS
4 out of 5 of the following conditions:
- High blood pressure (requiring medication)
- High cholesterol (requiring medication)
- Cardiovascular disease
- Diabetes melitus
- Obstructive sleep apnoea
For more information about Mounjaro from NCL ICB please click here